Skip to search formSkip to main contentSkip to account menu

TAD regimen

Known as: Thioguanine-AraC-Daunorubicin Regimen 
A regimen consisting of thioguanine, cytarabine (Ara-C) and daunorubicin used for the initial treatment of adult acute myelogenous leukemia (AML).
National Institutes of Health

Related topics

Related topics

6 relations
CytarabineDAT regimenDaunorubicinLeukemia, Myelocytic, Acute

Broader (1)

cytarabine/daunorubicin/thioguanine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Exercício físico na diabetes: missão impossível ou uma questão de motivação?
2013
2013
Cytotoxicity Of Orthodontic Temporary Anchorage Devices In Vitro
CYTOTOXICITY OF ORTHODONTIC TEMPORARY ANCHORAGE DEVICES ON HUMAN PERIODONTAL LIGAMENT FIBROBLASTS IN VITRO Manika Patwari, D.M.D… 
2012
2012
NFAT1 C-Terminal Domains Are Necessary but Not Sufficient for Inducing Cell Death
The proteins belonging to the nuclear factor of activated T cells (NFAT) family of transcription factors are expressed in several… 
2011
2011
Tres modalidades de diálogo entre APOS y TAD
We present three dialogue modes among research theories or approaches in mathematics education, starting from a new… 
2010
2010
Diagnóstico de la hipertensión arterial basado en el cálculo de la tensión arterial media
Objetivo: Definir si la tension arterial (TA) sistolica (TAS), diastolica (TAD) o media (TAM) son factores de riesgo de… 
2004
2004
Strahlenreaktionen in Polymeren
Die durch ionisierende Strahlen ausgel6sten Reaktionen haben im Laufe der letzten Jahre ein breites und sich best~indig… 
2003
2003
Precaución, riesgo y sostenibilidad en los organismos agrícolas modificados genéticamente
El cultivo y la comercializacion de Organismos Agricolas Modificados Geneticamente (0MG) es origen de multitud de importantes… 
1997
1997
Lack of Correlation Between Multi-Drug Resistance Expression and Clinical Response to Chemotherapy in Patients with Acute Myeloid Leukemia
Expression of the multi-drug-resistance (MDR) protein gpl70 encoded by the mdrl gene has been implied to play a role in acute… 
1996
1996
Hematologic and Therapeutic Effects of High-Dose AraC/Mitoxantrone (HAM) in the Induction Treatment of Patients with Newly Diagnosed AML. A Trial by AML Cooperative Group
In a multicenter randomised trial in newly diagnosed AML under age 60 double induction using TAD-HAM was more effective than TAD… 
1990
1990
Mard u parassiti tad-dielja
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)